Immunological approaches to the breakdown of hepatitis B viral persistence.
Lau
G K
GK
Division of Gastroenterology and Hepatology, University Department of Medicine, Queen Mary Hospital, Hong Kong, China.
Wang
B
B
Carman
W
W
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D013947:Thymosin / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D017325:Hepatitis B Vaccines; D016898:Interferon-alpha; D013947:Thymosin